Luzsana

Luzsana Biotechnology™ (Luzsana) is a global, purpose-driven innovative pharmaceutical company with the mission to provide accessible and affordable medicines for anyone, anywhere. The name Luzsana originates from "la luz" in Spanish and "sana" in Latin, meaning light and healing, respectively. As a healthcare company, Luzsana aspires to become the "light of healing" in the biotechnology field by prioritizing the well-being of all stakeholders. Through strategic initiatives with its parent company, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana co-develops innovative drugs in North America, Europe, and Japan, focusing on areas with high commercial medical needs. Currently, the company’s pipeline includes 11 high-potential oncology and non-oncology projects spanning all development stages from preclinical to Phase III, with plans to further diversify over time. These projects aim to address regions with highly unmet medical needs, some of which have best-in-class potential.